(Q53908240)

22 May 2018

title

Time course of pharmacodynamic and pharmacokinetic effects of physostigmine assessed by functional brain imaging in humans. (English)

1 reference

22 May 2018

1 reference

1 reference

functional brain imaging

1 reference

1 reference

22 May 2018

Mark B Schapiro

object named as

Schapiro MB

1 reference

22 May 2018

Gene E. Alexander

object named as

Alexander GE

1 reference

22 May 2018

author name string

Furey ML

1 reference

22 May 2018

Mentis MJ

1 reference

22 May 2018

Szczepanik J

1 reference

22 May 2018

Shetty U

1 reference

22 May 2018

Greig NH

1 reference

22 May 2018

Holloway HW

1 reference

22 May 2018

Freo U

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

22 May 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

22 May 2018

volume

1 reference

22 May 2018

issue

1 reference

22 May 2018

page(s)

475-481

1 reference

22 May 2018

Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Dementia and working memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

The decline of working memory in Alzheimer's disease. A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Statistical parametric maps in functional imaging: A general linear approach

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Solid phase extraction for an improved assay of physostigmine in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900186-6

7 January 2021

10.1016/S0091-3057(00)00186-6

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018